Cyclic Peptide [R
Adolescent
Adult
Aged
Antibiotics, Antitubercular
/ pharmacology
Autophagy
/ drug effects
Cytokines
/ metabolism
Drug Therapy, Combination
Granuloma
/ drug therapy
Host-Pathogen Interactions
Humans
Isoniazid
/ pharmacology
Microbial Viability
/ drug effects
Middle Aged
Mycobacterium tuberculosis
/ drug effects
Oxidative Stress
Peptides, Cyclic
/ pharmacology
Pyrazinamide
/ pharmacology
Tuberculosis
/ drug therapy
Young Adult
antimicrobial peptides
cyclic peptide
cytokine
host–bacteria interaction
tuberculosis
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
02
2020
accepted:
23
06
2020
entrez:
25
9
2020
pubmed:
26
9
2020
medline:
14
4
2021
Statut:
epublish
Résumé
Tuberculosis (TB) is currently one of the leading causes of global mortality. Medical non-compliance due to the length of the treatment and antibiotic side effects has led to the emergence of multidrug-resistant (MDR) strains of
Identifiants
pubmed: 32973740
doi: 10.3389/fimmu.2020.01677
pmc: PMC7438584
doi:
Substances chimiques
Antibiotics, Antitubercular
0
Cytokines
0
Peptides, Cyclic
0
cyclic peptide R4W4
0
Pyrazinamide
2KNI5N06TI
Isoniazid
V83O1VOZ8L
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1677Subventions
Organisme : NHLBI NIH HHS
ID : R15 HL143545
Pays : United States
Informations de copyright
Copyright © 2020 Hernandez, Ashley, Cao, Abrahem, Nguyen, To, Yegiazaryan, Akinwale David, Kumar Tiwari and Venketaraman.
Références
Semin Immunol. 2014 Jun;26(3):203-9
pubmed: 24819298
Mol Pharm. 2013 Feb 4;10(2):488-99
pubmed: 23301519
Antimicrob Agents Chemother. 2018 Oct 24;62(11):
pubmed: 30126957
Am J Respir Cell Mol Biol. 2011 Jul;45(1):172-80
pubmed: 20889800
Biotechnol Lett. 2020 Apr;42(4):657-668
pubmed: 31989342
J Biol Chem. 1992 Mar 15;267(8):5317-23
pubmed: 1312087
Crit Rev Eukaryot Gene Expr. 2010;20(2):87-103
pubmed: 21133840
Mediators Inflamm. 2014;2014:628748
pubmed: 24803741
FASEB J. 2016 Dec;30(12):3961-3978
pubmed: 27601442
Oxid Med Cell Longev. 2018 Oct 11;2018:7695364
pubmed: 30405878
Clin Immunol. 2004 Jan;110(1):2-12
pubmed: 14986673
Inflamm Allergy Drug Targets. 2009 Mar;8(1):53-62
pubmed: 19275693
Biochem J. 1987 Jul 1;245(1):243-50
pubmed: 3117042
Curr Pharm Des. 2010;16(28):3185-203
pubmed: 20687878
Nat Med. 2013 Feb;19(2):115
pubmed: 23389590
Methods Mol Biol. 2008;445:77-88
pubmed: 18425443
Cell Death Dis. 2018 Sep 17;9(10):934
pubmed: 30224639
Med Res Rev. 2020 Mar;40(2):753-810
pubmed: 31599007
Molecules. 2018 Aug 20;23(8):
pubmed: 30127265
Mol Pharm. 2014 Oct 6;11(10):3528-36
pubmed: 25157458
Curr Med Chem. 2009;16(24):3152-67
pubmed: 19689289
Trends Microbiol. 2005 Mar;13(3):98-102
pubmed: 15737727
Front Immunol. 2013 Jan 31;4:10
pubmed: 23386849
J Clin Med. 2019 Sep 27;8(10):
pubmed: 31569759
Sci Transl Med. 2014 Nov 19;6(263):263ra159
pubmed: 25411472
Front Immunol. 2018 Sep 12;9:2069
pubmed: 30258443
Nat Rev Microbiol. 2017 Jul;15(7):385-396
pubmed: 28420885
Molecules. 2017 Jun 08;22(6):
pubmed: 28594345
Molecules. 2018 Oct 22;23(10):
pubmed: 30360400
Angew Chem Int Ed Engl. 2011 Oct 4;50(41):9633-7
pubmed: 21919161
Curr Opin Chem Biol. 2017 Jun;38:24-29
pubmed: 28249193
Cancer Lett. 2015 Oct 28;367(2):103-7
pubmed: 26188281
J Biol Chem. 2018 Mar 2;293(9):3134-3144
pubmed: 29301939